Investment Analysts’ updated eps estimates for Tuesday, August 8th:

Brookfield Renewable Partners L.P. (NYSE:BEP) (TSE:BEP) was downgraded by analysts at National Bank Financial from an outperform rating to a sector perform rating. The firm currently has $35.00 price target on the stock.

DIALOG SEMICONDUCT GBP0.10 (NASDAQ:DLGNF) had its buy rating reiterated by analysts at DZ Bank AG.

Deutsche Post AG (OTCMKTS:DPSGY) had its buy rating reissued by analysts at DZ Bank AG.

Kopin Corporation (NASDAQ:KOPN) had its hold rating reissued by analysts at Needham & Company LLC. The analysts wrote, “While Kopin gave a significant 2H17 guide (rev. up 70% compared to 1H17) and spoke towards AR/VR headset traction (5 to be introduced by years end) as well as progress on its Whisper Chip technology, we remain cautious towards its near term prospects as business remains lumpy. We could become more constructive on the name if we see a clear inflection point in its business lines as we believe Kopin is targeting major areas of growth in the semiconductor space: AR/VR, voice HMI, and OLED.””

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom. “

Roth Capital started coverage on shares of Form Holdings Corp (NASDAQ:VRNG). The firm issued a buy rating and a $3.00 target price on the stock.

Virtusa Corporation (NASDAQ:VRTU) had its hold rating reaffirmed by analysts at Maxim Group.

WageWorks (NYSE:WAGE) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “WageWorks, Inc. is an on-demand provider of tax-advantaged programs for consumer-directed health, commuter and other employee spending account benefits, or CDBs, in the United States. The Company administers and operates an array of CDBs, including spending account management programs, such as health and dependent care flexible spending accounts, health savings accounts, health reimbursement arrangements and commuter benefits, such as transit and parking programs. The Company delivers its CDB programs through a benefits-as-a-service delivery model. WageWorks, Inc. is headquartered in San Mateo, California. “

Encore Wire Corporation (NASDAQ:WIRE) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Encore Wire Corporation is a low-cost manufacturer of copper electrical building wire and cable. The Company is a significant supplier of both residential wire for interior electrical wiring in homes, apartments and manufactured housing, as well as building wire for electrical distribution in commercial and industrial buildings. “

World Acceptance Corporation (NASDAQ:WRLD) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “World Acceptance Corporation is engaged in the small-loan consumer finance business, offering short-term small loans, medium-term larger loans, related credit insurance and ancillary products and services to individuals. “

Exco Technologies Limited (TSE:XTC) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. The firm currently has C$12.50 price target on the stock, down from their previous price target of C$15.00.

Zimmer Biomet Holdings (NYSE:ZBH) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Zimmer Biomet ended the second quarter on a mixed note. While earnings topped the Zacks Consensus Estimate, revenues remained in line with the same. We are disappointed by the company's declining sales performance within several of its core segments. Moreover, the market seems to be apprehensive about the departure of Zimmer’s decade old CEO David C. Dvorak. Zimmer Biomet has been lagging the broader industry with respect to share price movement over the last three months. The trimmed 2017 guidance adds to our concerns indicating little chances of recovery ahead. Nevertheless, improved gross and operating margin performance was encouraging. We look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed.”

Receive News & Ratings for Brookfield Renewable Partners LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookfield Renewable Partners LP and related companies with MarketBeat.com's FREE daily email newsletter.